1. Home
  2. |Insights
  3. |An Open Discussion with Richard A. Feinstein, Director, Bureau of Competition, Federal Trade Commission

An Open Discussion with Richard A. Feinstein, Director, Bureau of Competition, Federal Trade Commission

Event | 03.31.11, 12:00 AM UTC - 12:00 AM UTC

The program will focus on current topics in antitrust litigation, such as the application of Section 5 and antitrust/intellectual property issues related to standard-setting. Richard Feinstein will also discuss best practices for counsel when appearing before the FTC and share some thoughts about what to expect from the agency in the future.

Rob Lipstein is one of the moderators.

Click to view the invitation

Insights

Event | 12.04.25

ACI 30th Annual Conference on Drug & Medical Device Litigation

Dan Campbell with Speak on the panel "Mastering MDL Case Management: What Proposed Rule 16.1 Really Means for Consolidated Litigation."
Rule 16.1 attempts to guide early case management in MDLs, impacting litigation pace and costs. Permissive language like “should” instead of “must”, could lead to inconsistent applications. This panel will explore the rule’s anticipated impact and implications for procedures.